Search clinical trials for: ACT-451840

Total 1106 results

Idorsia Pharmaceuticals Ltd.

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-451840 in Healthy Subjects (Part A)

Healthy

France
Idorsia Pharmaceuticals Ltd.

Completed

Effect of ACT-451840 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Subjects

Healthy Subjects

Australia
Pharmacia and Upjohn

Completed

A Study of Different Doses of Atevirdine Mesylate Plus Zidovudine in HIV-Positive Patients

HIV Infections

United States
Centre Hospitalier Universitaire de Nīmes

Completed

The Point of View of Adolescents Who Have Undergone a Suicidal Act: What do They Expect From Their Relationship With Their Doctor? (Attente_ado)

Suicidal Act

France
Swansea University

Completed

Study Protocol for a Feasibility Study of a Novel ACT-based eHealth Psychoeducational Intervention for Students With Mental Distress

A Bite of ACT' (BOA) Acceptance and Commitment Therapy Online Psychoeducation Course | A Wait-list Control

United Kingdom
South West Yorkshire Partnership NHS Foundation...

Unknown

Service Users' Perspective of Reasons for Detention Under Section 136 of the Mental Health Act 1983

Reasons for Detention Under Mental Health Act 1983

United Kingdom
ACT Genomics
Chi Mei Medical Hospital

Unknown

Analysis of Tumor Mutations and Tumor Microenvironment Using Archival Paraffin-embedded Tumor Specimens

Sequence Analysis

Taiwan
Idorsia Pharmaceuticals Ltd.

Completed

Single-ascending Oral Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-281959 / ACT-246475 in Healthy Male Subjects

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics

France
Saint Joseph Mercy Health System

Completed

EMail Reminder to Follow up With Primary Physician

Act Code - Emergency
Nantes University Hospital
Institut de Recherche en Santé Publique, France

Unknown

Impact of a Therapeutic Education Program on the Acceptance of Disease and Management of Care (EDUPACT)

Chronic Disease

France
The Miriam Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Exercise Values of Life and Vitality Everyday (EVOLVE)

Physical Activity | Exercise | Behavior | Lifestyle | Acceptance and Commitment Therapy | ACT | Lifestyle, Sedentary

United States
Idorsia Pharmaceuticals Ltd.

Completed

Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-389949

Healthy Subjects

Netherlands
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Assess the Tolerability, Safety, Pharmacodynamics, and Pharmacokinetics of Ascending Single Doses (Including Food Interaction) and Ascending Multiple Doses of ACT-453859, and Multiple Doses of Setipiprant (ACT-129968)

Healthy
ACT Biotech, Inc

Completed

A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer

Gastric Cancer

Spain, United States
Actelion

Completed

Mass Balance, Pharmacokinetics, and Metabolism of 14C-labeled ACT-128800 Administered to Healthy Male Subjects

Pharmacokinetics

Switzerland
Idorsia Pharmaceuticals Ltd.

Terminated

A Study in Healthy Subjects to Investigate the Safety and Tolerability of ACT- 541478 as Well as What ACT-541478 Does to the Body and the Way the Body Takes up, Distributes, and Gets Rid of ACT-541478

Healthy

Germany
Idorsia Pharmaceuticals Ltd.

Completed

Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-389949 in Healthy Subjects

Healthy Subjects

United Kingdom
University of Coimbra
Fundação para a Ciência e a Tecnologia

Unknown

iACT With Pain: an ICT-delivered Intervention for Self-management of Chronic Pain (iACT)

Chronic Pain
Harvard School of Public Health (HSPH)

Completed

Preserving ACTs - Text Reminders to Increase Adherence to ACT Treatment (PACT)

Malaria

Ghana
Karolinska Institutet
Region Stockholm; Forte; Stiftelsen Frimurarna Barnhuset

Active, not recruiting

Internet-delivered ACT (I-Navigator ACT) for Parents of Children With Disabilities

Depression | Stress, Psychological | Intellectual Disability | Anxiety | Neurodevelopmental Disorders | Traumatic Brain Injury | Autism Spectrum Disorder | Parents | Attention Deficit Hyperactivity Disorder | Physical Disability

Sweden
Actelion

Completed

Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-128800 in Healthy Subjects

Safety and Tolerability

United Kingdom
University of Nottingham

Unknown

Effectiveness of Acceptance and Commitment Therapy Self-Help for Carers of People With Multiple Sclerosis

Carer Stress Syndrome

United Kingdom
Azusa Pacific University

Withdrawn

Culturally Tailored ACT for Black Trauma

Anxiety Disorders | Stress Disorders, Traumatic | Anxiety

United States
Idorsia Pharmaceuticals Ltd.

Completed

Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-462206

Pharmacokinetics | Pharmacodynamics | Tolerability | Safety

Netherlands
Idorsia Pharmaceuticals Ltd.

Completed

A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease

Stable Coronary Artery Disease

Denmark, Netherlands, Singapore, Canada, United Kingdom, United States, Germany, Sweden
Georgia State University

Recruiting

Calling All Dads! Evaluation of APAs ACT Program: Engaging Fathers to Prevent Adverse Childhood Experiences (CAD)

Child Abuse

United States
Actelion

Completed

Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female Subjects

Pharmacokinetics | Tolerability | Safety | Cardiodynamics

United States
Actelion

Completed

Study in Healthy Male Subjects to Demonstrate Bioequivalence of 1600 μg Selexipag Administered as Eight Tablets of 200 μg or as Single Tablet of 1600 μg

Bioequivalence

Netherlands
Case Comprehensive Cancer Center

Recruiting

Patient Navigator PRE-ACT Educational Intervention to Promote Decision Making Among Minorities

Educational Intervention | Minorities

United States
Region Skane
Lund University

Recruiting

A Comparison of Two Ultra-brief Interventions in Primary Care for Patients With Anxiety, Depression, and Stress. (RNTACTSweden)

Anxiety | Mental Disorder | Mental Stress | Mental Depression | Mental Health Issue | Rumination - Thoughts

Sweden
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of ACT-541468 in Healthy Young Adults and Elderly Subjects

Healthy Subjects

Netherlands
Alzheimer's Disease Expert Lab (ADEL), Inc.
Oscotec Inc.

Recruiting

A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01

Alzheimer Disease

United States
Gasherbrum Bio, Inc

Completed

A Study of Multiple Ascending Doses of GSBR-1290 in Japanese and Non-Japanese Healthy Participants

Healthy Volunteers

United States
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects

Healthy

Netherlands
Idorsia Pharmaceuticals Ltd.

Completed

Clinical Study to Assess the Pharmacokinetics, Safety, and Tolerability of ACT-129968 in Healthy Subjects

Healthy Subjects

Germany
Aspire Health Science

Unknown

ACT-20 in Patients With Severe COVID-19 Pneumonia

COVID-19 Pneumonia
Chinese University of Hong Kong
Hong Kong Young Women's Christian Association; Hong Kong Christian Service; Hong... and other collaborators

Recruiting

Pai.ACT - An Artificial Intelligence Driven Chatbot Assisted ACT

Intellectual Disability | Neurodevelopmental Disorders | Autism Spectrum Disorder | Attention Deficit Hyperactivity Disorder | Communication Disorders | Specific Learning Disorder | Motor Disorders

Hong Kong
Region Skane

Withdrawn

Acceptance and Commitment Based Group Therapy for Cancer Patients

Cancer | Psychological Distress

Sweden
Duke University
National Institute of Allergy and Infectious Diseases (NIAID); Moi University; Clinton Health Access Initiative, Nigeria

Completed

Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: the TESTsmART Trial AIM 1 (TESTsmART)

Malaria | Febrile Illness

Kenya
VA Office of Research and Development
University of Alabama, Tuscaloosa

Recruiting

Telehealth Acceptance and Commitment Therapy for Older Veterans Experiencing Pandemic-Related Stress (Pan-ACT)

Psychological Stress

United States
Tel Aviv University

Completed

Attention Control Treatment for Post Traumatic Stress Disorder ׂ(PTSD)

PTSD

Israel
Uppsala University

Terminated

Psychological Treatment in Psychiatric Inpatient Care

Psychosis | Psychiatric Disorder | Psychiatric Hospitalization | Compulsory Psychiatric Care Act | Acceptance & Commitment Therapy

Sweden
Idorsia Pharmaceuticals Ltd.

Completed

A Single Ascending Dose Study of ACT-541468 in Healthy Male Subjects

Healthy Subjects

Netherlands
King's College London
Guy's and St Thomas' NHS Foundation Trust

Recruiting

Group ACT for CD Pain- a Feasibility Study

Chronic Pain | Crohn Disease

United Kingdom
University of Oxford
Oxford University Hospitals NHS Trust; Oxford Health NHS Foundation Trust

Completed

Fluid Restriction and Quality of Life on Dialysis

End Stage Renal Disease

United Kingdom
University of Alabama at Birmingham

Withdrawn

A Coach-Guided Online Acceptance and Commitment Therapy (ACT) Intervention for Stroke Survivors

Depression | Stroke | Stress | Anxiety

United States
Rikard Wicksell
Region Stockholm; Skandia Insurance Company, Ltd.

Completed

ACT for ME/CFS - an Open Case Trial

Chronic Fatigue Syndrome

Sweden
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of ACT-1004-1239 in Healthy Male Subjects

Healthy

United States
University College Dublin

Completed

Acceptance and Commitment Therapy (ACT) in Inflammatory Bowel Disease

Inflammatory Bowel Disease

Ireland
Aeonvital Biomedicine

Not yet recruiting

A Phase I Study on ReT01 ACT for the Treatment of Advanced Solid Tumors

Advanced Solid Tumor

Search clinical trials for: ACT-451840

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations